Most Recent
In defeat for IP Australia, Rokt wins patent for computer software
Rokt has won its bid to patent a digital advertising system, the first major court victory in one of three challenges to IP Australia's stance on the patentability of computer software.
Motorola to bring copyright claims against Hytera
Motorola Solutions wants to amend its pleadings in an ongoing patent case against Shenzen-based Hytera Communications to add copyright claims relating to the source code for the radio devices at the centre of the dispute.
‘Ingenuity’ needed for software-aided biz method patent, IP Australia says
A software-implemented business method could be patentable if programmed into a computer with "some ingenuity", IP Australia told the Full Federal Court as a landmark appeal between rival tech companies Encompass and Infotrack wrapped up Friday.
Alphapharm slams Sanofi amendment delay in injunction battle
Generic drug maker Alphapharm says rival Sanofi-Aventis waited to amend its injector pen patent until the heated IP battle between the two firms had commenced, despite knowing about the amendments for three years.
Alphapharm loses bid for docs in Sanofi injector pen patent dispute
Generic drug maker Alphapharm has lost another bid for documents from Sanofi-Aventis in advance of a hearing on Sanofi's interlocutory application seeking to block the generic drug maker from listing its injector pen on the Pharmaceutical Benefits Scheme.
IP lawyers seek to intervene in software patent appeal
A group representing patent and trade mark lawyers is seeking to intervene in a high-stakes appeal over computer software patents.
VisionSearch takes final shot at ObjectiVision’s ‘limited’ case
ObjectiVision has presented a "limited" and "debatable" case that its source code for a glaucoma testing device was copied, the Federal Court heard Thursday as the trial in a four-year spat with the University of Sydney over IP rights came to a close.
Motorola says Hytera misled court, wins discovery request
Motorola Solutions says Hytera Communications misled the Federal Court about key decision makers involved in the development of radio products which it claims infringe three of its patents.
Alphapharm says Sanofi patent amendment should doom injunction bid
Generic drug maker Alphapharm is fighting a bid by global pharmaceutical giant Sanofi-Aventis to block the listing of one of its injector pens, saying the proposed injunction should be denied because Sanofi is seeking to amend the patent at issue.
Foxtel should pay more than a gym to stream copyrighted recordings, court told
A Copyright Tribunal decision that led to substantially lower sound recording licence fees for Foxtel was "beyond the pale" because it compared fees charged to the cable TV giant with those charged to fitness centres, the Full Federal Court heard Wednesday.